Patient satisfaction rating scales <i>v.</i> patient-related outcome and experience measures

Abstract

evidence suggesting or demonstrating harm has grown'. He concludes that 'mounting awareness of the probable futility of antipsychotic polypharmacy is reflected in the latest guidance issued by the National Institute for Health and Clinical Excellence'.